# Valentin Piech

> Valentin Piech is a seed investor at VP Venture Partners backing Health Care and Life Science. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [VP Venture Partners](https://shizune.co/investors/profile/vp-venture-partners-ea26)
- Location: Basel, Switzerland
- Total investments: 2
- Last investment: Jun 2026
- Lead investor: 0%
- Last updated: Aug 2026

Valentin Piech is a seed investor at VP Venture Partners in Basel focused on Health Care and Life Science. Valentin Piëch is the Founder of VP Venture Partners.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Life Science | 1 | 50% |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series B | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CollimateHealth | CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer. | $6.9M | Seed | Jun 12, 2026 |  |
| Tubulis | Tubulis is a biotechnology company that develops antibody-drug conjugates (ADCs) for targeted cancer therapy. The company combines proprietary technologies with disease-specific biological insights to create highly stable and effective protein-drug conjugates. Its platform enables the design of ADCs with improved delivery, reduced toxicity, andenhanced therapeutic potential across various cancer types, including solid and hematologic tumors. Tubulis is advancing a pipeline of experimental drug candidates, such as TUB-040 and TUB-030, which are currently being evaluated in clinical settings for cancers like ovarian and lung cancer. The company also collaborates with industry partners and leverages its proprietary conjugation technologies to expand the scope and effectiveness of targeted oncology treatments. | $63.2M | Series B | May 03, 2022 |  |

2 of 2 investments shown.

## Co-investors
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund, 2 deals together
- [Bayern Kapital](https://shizune.co/investors/profile/bayern-kapital) — VC Fund, 1 deal together
- [Caesar Ventures](https://shizune.co/investors/profile/caesar-ventures-llc) — VC Fund, 1 deal together
- [coparion](https://shizune.co/investors/profile/coparion) — VC Fund, 1 deal together
- [Andera Partners](https://shizune.co/investors/profile/edmond-de-rothschild-investment-partners) — VC Fund, 1 deal together
- [Evotec](https://shizune.co/investors/profile/evotec-inc) — VC Fund, 1 deal together

## About VP Venture Partners

VC Fund · Zürich, Switzerland

VP Venture Partners is a venture capital firm invests in healthcare companies.

2 contacts available at VP Venture Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Valentin Piech | Founder | https://shizune.co/investors/profile/valentin-piech |
| Ruth Ketley | Senior Associate | https://shizune.co/investors/profile/ruth-ketley |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Valentin Piech invest in?

Valentin Piech invests primarily in Health Care, Life Science and Therapeutics startups, most often at Seed and Series B stage. Most of the 2 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Valentin Piech last invest?

The most recent investment recorded for Valentin Piech closed in Jun 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co